Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study

Endocrine

Volumn 50, Issue 2, 2015, Pages 390-396

  Hashimoto, Yoshitaka ^a   Tanaka, Muhei ^a   Kimura, Toshihiro ^a   Kitagawa, Noriyuki ^a   Hamaguchi, Masahide ^a   Asano, Mai ^a   Yamazaki, Masahiro ^a   Oda, Yohei ^a   Toda, Hitoshi ^b   Nakamura, Naoto ^a   Fukui, Michiaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Oike Clinic   (Japan)

Author keywords

Epidemiology; Hematological parameters; Hemoglobin; Metabolic syndrome

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TREND STUDY; BLOOD; INCIDENCE; JAPAN; MEAN CORPUSCULAR VOLUME; PHYSIOLOGY;

ADULT; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84945472328     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0587-9     Document Type: Article

References (41)

1. J.I. Cleeman, S.M. Grundy, D. Becker, L.T. Clark, Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)
2. H. Sone, S. Tanaka, S. Iimuro, K. Oida, Y. Yamasaki, S. Oikawa, S. Ishibashi, S. Katayama, H. Ito, Y. Ohashi, Y. Akanuma, N. Yamada, Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). J. Atheroscler. Thromb. 16, 380–387 (2009)
3. S. Nagahama, K. Kurotani, N.M. Pham, A. Nanri, K. Kuwahara, M. Dan, Y. Nishiwaki, T. Mizou, Self-reported eating rate and metabolic syndrome in Japanese people: cross-sectional study. BMJ Open (2014). doi:10.1136/bmjopen-2014-005241
4. N. Miyatake, Y. Kawasaki, H. Nishikawa, S. Takenami, T. Numata, Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern. Med. 45, 107–108 (2006)
5. V. Lohsoonthorn, W. Jiamjarasrungsi, M.A. Williams, Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand. Diabetes Metab. Syndr. 1, 143–149 (2007)
6. K. Nebeck, B. Gelaye, S. Lemma, Y. Berhane, T. Bekele, A. Khali, Y. Haddis, M.A. Williams, Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia. Diabetes Metab. Syndr. 6, 22–27 (2012)
7. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, M. Abe, T. Katoh, Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine 43, 334–341 (2013)
8. Y.Y. Wang, S.Y. Lin, P.H. Liu, B.M. Cheung, W.A. Lai, Association between hematological parameters and metabolic syndrome components in a Chinese population. J. Diabetes Complications 18, 322–327 (2004)
9. F.S. Facchini, M. Carantoni, J. Jeppesen, G.M. Reaven, Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47, 831–835 (1998)
10. K.M. Choi, J. Lee, Y.H. Kim, K.B. Kim, D.L. Kim, S.G. Kim, D.H. Shin, N.H. Kim, I.B. Park, D.S. Choi, S.H. Baik, Koreans-Southwest Seoul (SWS) Study, Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res. Clin. Pract. 60, 205–212 (2003)
11. Y. Li, L. Liu, B. Wang, J. Wang, D. Chen, Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis. Eur. J. Gastroenterol. Hepatol. 26, 332–338 (2014)
12. S.G. Wannamethee, I.J. Perry, A.G. Shaper, Hematocrit and risk of NIDDM. Diabetes 45, 576–579 (1996)
13. L.J. Tamariz, J.H. Young, J.S. Pankow, H.C. Yeh, M.I. Schmidt, B. Astor, F.L. Brancati, Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am. J. Epidemiol. 168, 1153–1160 (2008)
14. N. Nakanishi, K. Suzuki, K. Tatara, Haematocrit and risk of development of Type 2 diabetes mellitus in middle-aged Japanese men. Diabetes Med. 21, 476–482 (2004)
15. M.K. Tulloch-Reid, R.L. Hanson, A. Saremi, H.C. Looker, D.E. Williams, J. Krakoff, W.C. Knowler, Hematocrit and the incidence of type 2 diabetes in the pima indians. Diabetes Care 27, 2245–2246 (2004)
16. Y. Jiang, J. Zeng, B. Chen, Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver. J. Gastroenterol. Hepatol. 29, 1508–1514 (2014)
17. D.R. Gagnon, T.J. Zhang, F.N. Brand, W.B. Kannel, Hematocrit and the risk of cardiovascular disease—the Framingham study: a 34-year follow-up. Am. Heart J. 127, 674–682 (1994)
18. D.W. Brown, W.H. Giles, J.B. Croft, Hematocrit and the risk of coronary heart disease mortality. Am. Heart J. 142, 657–663 (2001)
19. T. Kunnas, T. Solakivi, K. Huuskonen, A. Kalela, J. Renko, S.T. Nikkari, Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up. Prev. Med. 49, 45–47 (2009)
20. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, K. Nitta, K. Yamagata, Y. Tomino, H. Yokoyama, A. Hishida, Collaborators developing the Japanese equation for estimated GFR, Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982–992 (2009)
21. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120, 1640–1645 (2009)
22. T. Ota, T. Takamura, N. Hirai, K. Kobayashi, Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care 25, 1252–1253 (2002)
23. M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, K. Fujii, T. Omatsu, T. Nakajima, H. Sarui, M. Shimazaki, T. Kato, J. Okuda, K. Ida, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 143, 722–728 (2005)
24. T. Nakamura, Y. Tsubono, K. Kameda-Takemura, T. Funahashi, S. Yamashita, S. Hisamichi, T. Kita, T. Yamamura, Y. Matsuzawa, Group of the research for the association between host origin and atherosclerotic diseases under the preventive measure for work-related diseases of the Japanese Labor Ministry.: magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case-control study. Jpn. Circ. J. 65, 11–17 (2001)
25. M.R. Carnethon, C.M. Loria, J.O. Hill, S. Sidney, P.J. Savage, K. Liu, Coronary artery risk development in young adults study: risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 27, 2707–2715 (2004)
26. J.P. Gonçalves, A. Oliveira, M. Severo, A.C. Santos, C. Lopes, Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 41, 450–457 (2012)
27. A. Moan, G. Nordby, I. Os, K.I. Birkeland, S.E. Kjeldsen, Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 43, 423–427 (1994)
28. G. de Simone, R.B. Devereux, S. Chien, M.H. Alderman, S.A. Atlas, J.H. Laragh, Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81, 107–117 (1990)
29. T.A. Schultz, S.B. Lewis, D.K. Westbie, J.D. Wallin, J.E. Gerich, Glucose delivery: a modulator of glucose uptake in contracting skeletal muscle. Am. J. Physiol. 233, E514–E518 (1997)
30. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe, Hemoglobin is associated with serum high molecular weight adiponectin in Japanese community-dwelling persons. J. Atheroscler. Thromb. 18, 182–189 (2011)
31. A. Sonmez, M.I. Yilmaz, M. Saglam, S. Kilic, T. Eyileten, G. Uckaya, K. Caglar, Y. Oguz, A. Vural, M. Yenicesu, M. Kutlu, C. Kinalp, C. Zoccali, The relationship between hemoglobin levels and endothelial functions in diabetes mellitus. Clin. J. Am. Soc. Nephrol. 5, 45–50 (2010)
32. W.A. Hsueh, M.J. Quiñones, Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 92, 10J–17J (2003)
33. T. Wang, Y. Bi, M. Xu, Y. Huang, Y. Xu, X. Li, W. Wang, G. Ning, Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40, 109–116 (2011)
34. Y. Xu, M. Xu, Y. Huang, T. Wang, M. Li, Y. Wu, A. Song, X. Li, Y. Bi, G. Ning, Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese. Endocrine 40, 265–272 (2011)
35. Y. Xu, Z. Zhao, X. Li, Y. Bi, M. Xu, G. Ning, Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine 39, 175–181 (2011)
36. Y. Xu, Y.F. Bi, M. Xu, Y. Huang, W.Y. Lu, Y.F. Gu, G. Ning, X.Y. Li, Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people. J. Diabetes. 3, 38–47 (2011)
37. M.A. Martínez-García, M. Luque-Ramírez, J.L. San-Millán, H.F. Escobar-Morreale, Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care 32, 1525–1530 (2009)
38. A. Ozdemir, C. Sevinç, U. Selamet, B. Kamaci, S. Atalay, Age- and body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women. Ann. Saudi. Med. 27, 356–361 (2007)
39. R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe, T. Katoh, N. Ohtsuka, Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine 44, 132–139 (2013)
40. Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity, New criteria for ‘obesity disease’ in Japan. Circ. J. 66, 987–992 (2002)
41. E.M. Miller, Iron status and reproduction in US women: National Health and Nutrition Examination Survey, 1999-2006. PLoS ONE (2014). doi:10.1371/journal.pone.0112216